GLP-1 receptor agonists — Ozempic, Wegovy, Mounjaro, and Zepbound — have produced some of the most dramatic weight loss results ever seen in clinical trials. In the SURMOUNT-1 trial, people on tirzepatide (Mounjaro/Zepbound) lost an average of 22.5% of their body weight. That’s 45 pounds for a 200-pound person.
The problem is the price. Without insurance coverage, these medications cost:
- Ozempic (semaglutide 0.5–2mg) — ~$900–$1,000/month
- Wegovy (semaglutide 2.4mg) — ~$1,300–$1,400/month
- Mounjaro (tirzepatide) — ~$900–$1,100/month
- Zepbound (tirzepatide for obesity) — ~$1,000–$1,100/month
That’s up to $16,800/year out of pocket. For most people, that’s not sustainable. But insurance coverage — and significant savings programs — exist for all of these medications. The system is just confusing enough that most people give up before finding them.
This guide walks you through every available coverage path, in order of effort required.
Path 1: Commercial Insurance Coverage
Private insurance through your employer or marketplace plan may cover GLP-1 medications, but coverage varies dramatically by plan and by the indication (the reason the drug is prescribed).
The Indication Matters More Than the Drug
This is the most important thing to understand: the same drug can be covered or denied based purely on why your doctor prescribes it.
| Drug | FDA Approved For | Insurance Typically Covers | Often NOT Covered |
|---|---|---|---|
| Ozempic (semaglutide) | Type 2 Diabetes | ✅ When prescribed for T2D | ❌ When prescribed for weight loss only |
| Wegovy (semaglutide) | Chronic Weight Management | ✅ If plan covers obesity drugs | ❌ Many plans exclude weight loss drugs |
| Mounjaro (tirzepatide) | Type 2 Diabetes | ✅ When prescribed for T2D | ❌ When prescribed off-label for weight loss |
| Zepbound (tirzepatide) | Chronic Weight Management | ✅ If plan covers obesity drugs | ❌ Many plans exclude weight loss drugs |
Key insight: If you have Type 2 diabetes or prediabetes with cardiovascular risk factors, Ozempic or Mounjaro prescribed for diabetes management is much more likely to be covered than Wegovy or Zepbound prescribed for obesity. Talk to your doctor about which indication applies to you.
How to Check Your Coverage
- Call the member services number on the back of your insurance card
- Ask: “Does my plan cover semaglutide (Ozempic or Wegovy) or tirzepatide (Mounjaro or Zepbound)?”
- Ask for the drug’s tier level and your out-of-pocket cost at that tier
- Ask if prior authorization is required (it almost always is)
- Ask what documentation is needed for prior authorization (BMI, medical history, previous weight loss attempts)
Prior Authorization — What Your Doctor Needs to Submit
Even if your plan covers GLP-1s, prior authorization is nearly universal. Your doctor’s office handles this, but you need to prompt them and follow up. The typical documentation required:
- BMI of 27+ with at least one weight-related comorbidity (high blood pressure, sleep apnea, type 2 diabetes, high cholesterol), OR BMI of 30+
- Documentation of previous weight loss attempts (diet programs, exercise, other medications)
- HbA1c and fasting glucose results if prescribing for diabetes
- Cardiovascular risk assessment for Ozempic (which has a cardiovascular outcomes benefit)
If prior authorization is denied, your doctor can file an appeal with additional clinical documentation. First-level appeals are successful in roughly 40% of cases. Do not accept an initial denial as final.
Path 2: Manufacturer Savings Programs (Fastest Route to Savings)
Novo Nordisk Savings Card (Ozempic & Wegovy)
Novo Nordisk offers a savings card that can reduce your monthly cost to as low as $25/month for eligible commercially insured patients. Eligibility requirements:
- Must have commercial insurance (not Medicare or Medicaid)
- Income limits apply for the lowest-tier savings
- Apply at novocare.com or ask your pharmacist
For uninsured patients, Novo Nordisk’s Patient Assistance Program (PAP) may provide Ozempic or Wegovy at no cost to qualifying low-income individuals. Apply at novonordisk-us.com/pap.
Eli Lilly Savings Card (Mounjaro & Zepbound)
Eli Lilly offers the Lilly Insulin Value Program and similar savings cards. Commercially insured Zepbound patients may pay as little as $25/month for the first 12 months. Apply at zepbound.com/savings or mounjaro.com/savings.
Lilly also runs the Lilly Cares Foundation patient assistance program for uninsured or underinsured patients with income below 400% of the federal poverty level.
Path 3: Medicare Coverage (What’s Changing)
This is where things are evolving fast. As of 2026:
- Medicare Part D covers Ozempic and Mounjaro when prescribed for Type 2 diabetes — the same as for commercially insured patients.
- Medicare has historically NOT covered Wegovy or Zepbound when prescribed purely for weight loss, due to a 1990s law excluding weight loss drugs from Medicare coverage.
- However: The Inflation Reduction Act provisions and proposed CMS rule changes have been moving toward covering GLP-1s for obesity under Medicare. Check the current CMS guidance at cms.gov as this is actively changing in 2026.
If you’re on Medicare with Type 2 diabetes, ask your doctor to prescribe Ozempic or Mounjaro under the diabetes indication. This is the fastest current route to Medicare coverage.
Path 4: Compounding Pharmacies (Lower Cost Alternative)
During the FDA shortage periods of 2023–2024, compounded semaglutide and tirzepatide became widely available through telehealth companies and compounding pharmacies at 60–80% lower cost. As of 2025–2026, the FDA has ended the shortage designation for branded GLP-1s, meaning compounded versions are no longer permitted except under specific circumstances.
Be cautious of any telehealth company still offering “compounded semaglutide” at dramatically lower prices — verify their FDA compliance status and your state’s regulations before purchasing.
Path 5: Clinical Trials
If you qualify, participating in a clinical trial can provide access to GLP-1 medications (or next-generation weight loss drugs) at no cost. Search clinicaltrials.gov for active obesity or diabetes trials in your area. University medical centers and large hospital systems run the most trials.
What to Do Right Now — The Exact Sequence
- Call your insurance today and ask the exact questions listed above — get a reference number for the call
- Schedule a specific appointment with your doctor to discuss GLP-1 coverage — don’t bring it up at the end of an appointment for something else
- Bring your insurance coverage findings to the appointment — your doctor needs to know which indication to use in the prescription
- Ask your doctor to submit prior authorization before you leave the office — or confirm they will do it within 48 hours
- Apply for the manufacturer savings card immediately as a backup, even if your insurance is being processed
- If denied: file an appeal with your doctor’s help within 30 days of denial; escalate to an external appeal if the internal appeal fails
Frequently Asked Questions
Can I use GoodRx for Ozempic or Wegovy?
GoodRx coupons provide limited discounts on GLP-1s — typically bringing the price down by 15–30% from list price, but still leaving monthly costs at $600–$900. GoodRx is better as a backup than a primary savings strategy for these medications. Note: you cannot use GoodRx at the same time as your insurance or manufacturer savings card.
What if my employer’s plan doesn’t cover weight loss drugs?
During open enrollment, compare your employer’s plan options — some plans explicitly exclude weight loss drugs while others cover them. You can also purchase a separate individual health plan through healthcare.gov during a Special Enrollment Period if you have a qualifying life event. Some employer plans can be influenced by employee feedback — HR departments have responded to formal requests from employee groups.
How long will I need to take these medications?
Most clinical trial data shows that weight regain occurs when GLP-1 medications are discontinued. Current evidence suggests these are likely long-term medications for most patients, similar to statins for cholesterol. This makes long-term insurance coverage — not just short-term savings cards — the critical goal to pursue.